ResearcherNagoya City UniversityNo recent work listed

Midori Shimada

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2718-8600; OpenAlex author ID A5011309423. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2017: 1 paper

Papers 1

The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy. Last author DOI 10.1371/journal.pone.0178221 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Tsuyoshi Sano · 1 shared paper, 2017 · strength 0.06
- Paper The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemothera… DOI 10.1371/journal.pone.0178221 ↗
Tsutomu Iwata · 1 shared paper, 2017 · strength 0.06
- Paper The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemothera… DOI 10.1371/journal.pone.0178221 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.